Regulation And Legal
AstraZeneca Wins Tagrisso Patent Appeal, $7.2bn Revenue
US Federal Circuit upheld decision invalidating two Wyeth patents, favoring AstraZeneca in Tagrisso dispute.
Pfizer's Wyeth sued AstraZeneca in 2021 alleging Tagrisso infringed patents covering breast
